Feel Good Medicine

Feel Good War on Breast Cancer_300x500_scaled_cropp 2
  • Posted: May 8, 2013
  • Category: Blog
  • No Comments

I realize that I am treading on thin ice with this blog post. What I have to say might be perceived as being insensitive to gender issues. In addition, I might be perceived as being critical of medicine and those who practice it. While my post clearly points out the relevance to both sexes, I might be partially guilty on the medical charge. Those who know me are aware that I have issues with modern medicine, but I promise not to indulge in outrage. This time.

The New York Times published an article last Sunday on one breast cancer survivor’s view of the effort to detect and treat breast cancer. I think it well worth reading. The link to the article is below:

http://www.nytimes.com/2013/04/28/magazine/our-feel-good-war-on-breast-cancer.html?ref=magazine

To be honest, the article supported my well known pre-conceived ideas and prejudices. As a result, I would have let it pass without writing if it had not been in the New York Times. As you may know, the NY Times is a tireless cheerleader for the issues and groups talked about in the article. The Times printing this article is a bit like Christianity Today printing an article in support of gay rights. It is not only surprising but any concern about political agendas and ulterior motives is removed.

The article is not an expose of bad people, greedy people or evil corporations, though people and profitable companies are featured. The article is about the train crash that is modern medicine in the United States. A train wreck caused by our, yours and mine, inability to deal with uncertainty and risk. It is about the lack of a coherent narrative in our society about risk, commerce and responsibility.

The article focuses on breast cancer and the paradox of mammograms. We all know that mammograms are good. We all know that medicine, funded by all the activities supported by the color Pink, is doing everything it can to cure breast cancer. But medicine is composed of people, a multitude of people, from those who walk the 5 K’s to those working in the research laboratories. Everyone involved has only the best of intentions. But they all have house payments and would like to get promoted. And just like all of us, they like to feel good about what they do.

It is indeed unfortunate that the results of the mammograms are full of ambiguity. What do we do about that? The tests are ambiguous, but there is a lot of money to be made from the tests and the resulting treatments. In the article the author makes the case that a lot of money is spent for very little effect. She also makes the case that a great many people are harmed, with relatively few people helped. But efforts to weigh benefits against costs are easily demagogued. Besides, spending the money and getting the tests makes us feel good.

Some lines of research don’t get much money. Marginal treatment improvements are attractive because they are likely to succeed and can provide heart warming stories for the website and television. Everybody can sit back and bask in success. Careers are advanced and decision makers are lionized. On the other hand, research into fundamental causes and non-standard treatment options takes a very long time and usually leads nowhere. As you might guess, research failure is very bad because careers are affected and decision makers questioned. There might even be lawsuits and liability actions in the courts.

The article focuses on breast cancer, but it could have been as easily about prostate cancer. It is just that prostate cancer doesn’t have the Susan G. Komen foundation, the New York Times and the marketing bonanza that has developed. Yet.

Just as women get mammograms, men get PSA tests. I get my PSA test for prostate cancer every year, Since I have a history of prostate cancer in my family, it is very likely that I will be faced with a question similar to the one raised in the article some day. The PSA test, just like mammograms, diagnoses many phantom cancers. Again like the mammogram, the PSA test is unable to distinguish between relatively benign cases that do not require treatment and aggressive forms of the disease. And in a final similarity to mammograms, the PSA test frequently misses the really bad cases of the disease because the window in time for catching them is usually very short. There is also a substantial infrastructure that exists as a result of the PSA test for jobs, careers and invitations to benefit dinners with celebrity speakers.

What will I decide to do if and when my PSA test comes in with a bad number? I don’t know.

 

No Responses Yet to “Feel Good Medicine”

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

  • Email Updates

  • Categories

  • What I’m Reading

    Dark Star

    "Dark Star" Alan Furst

    “Lately my interest in the twists and turns who we are as human beings has led me to Detective Noir, crime or spy novels delving deeply into the dark recesses of the human personality. We may fool ourselves into a belief that we are somehow special, but we know that things could well be different.
    Dark Star, a novel by Alan Furst, is the compelling story of a cosmopolitan Russian foreign correspondent at a time when WWII looms on the horizon. Andre Sarza is a Jew, born in Poland, survivor of a hard childhood and Central Europe’s recurring pogroms. Inspired by the 1917 Revolution in Russia, he travels there and fights with the Red forces against the White armies in the vicious circumstances of the Ukraine. A talent for writing dispatches from the front lines brings him a job as foreign correspondent for Pravda, the Russian newspaper. Of course, a job as a foreign correspondent with Pravda brings along with it employment by the NKVD, the Soviet secret police, paranoid, randomly lethal and all knowing.
    We first meet Andre Sarza in Prague in 1937 as the Germans are beginning to frighten Europe, most especially Czechoslovakia. We are plunged into a time and place where nothing is as it seems, no one is who they seem to be and the stakes are life and death, particularly for a Jew. The Germans are everywhere, both the Gestapo and the Abwehr. Relentless purges back in Russia cause seemingly random executions to Sarza’s colleagues within the NKVD itself.
    Circumstance brings him to Paris, writing stories and making regular trips into Germany using his cover as a foreign correspondent for Pravda. In Berlin, he meets with a sympathetic Jewish factory owner to gather information on the strength of the Luftwaffe. MI-6 ensnares him further as the British trade precious slots on ships bound for Palestine to carry small numbers of Polish Jews in exchange for the information Sarza obtains on his trips into Germany for the NKVD.
    Andre Sarza is not a hero like James Bond or Jason Bourne. He is not even particularly brave or possessed of any great physical prowess. He simply does what he must to survive a time and place where not only are survival unlikely; but the differences between right and wrong are hidden in the murk of a plastic reality.

  • Recent Comments